AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
VRTX vs ZTS Fundamental Comparison
| Metric | VRTX | ZTS |
|---|---|---|
| Revenue | $3.0B | $2.3B |
| Net Income | $1.0B | $601.0M |
| Net Margin | 34.5% | 26.6% |
| ROE | 5.3% | 18.6% |
| ROA | 3.9% | 4.0% |
| Current Ratio | 3.02x | 3.15x |
| Debt/Equity | 0.01x | 2.80x |
| EPS | $4.02 | $1.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
VRTX vs ZTS: Frequently Asked Questions
Is VRTX or ZTS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. VRTX is graded A (81% confidence) while ZTS is graded A (78% confidence). This is not investment advice.
How does VRTX compare to ZTS fundamentally?
VERTEX PHARMACEUTICALS INC / MA has ROE of 5.3% vs Zoetis Inc.'s 18.6%. Net margins are 34.5% vs 26.6% respectively.
Which stock pays higher dividends, VRTX or ZTS?
VRTX has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in VRTX or ZTS for long term?
For long-term investing, consider that VRTX has a A grade with 81% confidence, while ZTS has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about VRTX vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For VRTX vs ZTS, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.